Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Pramipexole dihydrochloride

Pramipexole dihydrochloride

pharmaceutical raw materials
Pramipexole dihydrochloride structure

Pramipexole dihydrochloride 

structure
  • CAS No:

    104632-25-9

  • Formula:

    C10H17N3S.2ClH

  • Chemical Name:

    Pramipexole dihydrochloride

  • Synonyms:

    2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-,hydrochloride (1:2),(6S)-;2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-,dihydrochloride,(S)-;2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-,dihydrochloride,(6S)-;Pramipexole dihydrochloride;SND 19;Pramipexole hydrochloride

  • Categories:

    Active Pharmaceutical Ingredients  >  Nervous System Drugs

Description

White Crystalline PowderChEBI: A hydrochloride that is the anhydrous dihydrochloride salt of pramipexole.Mirapex, an non ergot derivative, was launched in the US for treatment of Parkinson's disease. It had an adverse events profile similar to other dopamine agonists and in advanced patients reduced the mean on-off hr/day from 6 to 4. It was safe but not efficacious in all patients.Pramipexole dihydrochloride,(S)-2-amino-6-propylamino-dihydrochloride(Mirapex), is a white to off-white powder


Pramipexole hydrochloride anhydrous is a hydrochloride that is the anhydrous dihydrochloride salt of pramipexole. It has a role as a dopamine agonist and an antiparkinson drug. It contains a pramipexole(2+).|A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.

Pramipexole dihydrochloride Basic Attributes

284.25

283.067688

1806241-263-5

4R2HD0M28N

DTXSID90146623

2934999090

Characteristics

79.2

4.15830

white crystalline powder

296-298 °C

378ºC at 760 mmHg

182.4ºC

H2O: >20mg/mL

Desiccate at RT

6.49E-06mmHg at 25°C

Safety Information

NONH for all modes of transport

3

P261, P264, P270, P272, P273, P280, P301+P312, P302+P352, P321, P330, P333+P313, P363, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P272, P273, P280, P301+P312, P302+P352, P321, P330, P333+P313, P363, and P501|Aggregated GHS information provided by 55 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)|Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)|Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)

2 Amino 6 propylaminotetrahydrobenzothiazole

Pramipexole dihydrochloride Use and Manufacturing

Uses

A dopamine-D2-receptor agonist. Antiparkinsonian

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:284.2
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:3
Exact Mass:283.0676742
Monoisotopic Mass:283.0676742
Topological Polar Surface Area:79.2
Heavy Atom Count:16
Complexity:188
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes

Recommended Suppliers of Pramipexole dihydrochloride

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.